// App-Quantinova.ai

THU0124 (2018) : Low inflammation on magnetic resonance imaging in patients with rheumatoid arthritis that achieved sustained clinical remission on adalimumab: data from the predictra study

Researchers

Presenter

  • P. Emery

Principal Investigators

  • G. Burmester

  • E. Naredo

  • I. Lagunes

  • Y. Zhang

  • X. Wang

  • M. Hojnik

  • P.G. Conaghan

Medical Centers

  • University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, UK

  • Charite-University Medicine Berlin, Berlin, Germany

  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

  • ABBVIE, N Chicago, USA

  • ABBVIE, Ljubljana, Slovenia

Locations

  • United Kingdom

  • Germany

  • Spain

  • United States

  • Slovenia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved